I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| neuron | 5 studies | 25% ± 13% | |
| glutamatergic neuron | 4 studies | 40% ± 20% | |
| retinal ganglion cell | 4 studies | 49% ± 29% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| neuron | 5 studies | 25% ± 13% | |
| glutamatergic neuron | 4 studies | 40% ± 20% | |
| retinal ganglion cell | 4 studies | 49% ± 29% |
Insufficient scRNA-seq data for expression of FSD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2542.07 | 2639 / 2642 | 100% | 42.23 | 703 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 66% | 4.34 | 19 / 29 |
| adrenal gland | 2% | 8.55 | 5 / 258 | 63% | 8.62 | 144 / 230 |
| spleen | 51% | 158.10 | 123 / 241 | 0% | 0 | 0 / 0 |
| skin | 21% | 125.19 | 381 / 1809 | 25% | 3.17 | 119 / 472 |
| ovary | 2% | 4.06 | 3 / 180 | 38% | 2.76 | 163 / 430 |
| uterus | 4% | 14.47 | 7 / 170 | 31% | 3.94 | 141 / 459 |
| bladder | 0% | 0 | 0 / 21 | 32% | 4.20 | 160 / 504 |
| peripheral blood | 26% | 105.79 | 237 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 1.46 | 10 / 45 |
| esophagus | 0% | 0.32 | 1 / 1445 | 21% | 1.40 | 38 / 183 |
| lung | 1% | 3.18 | 6 / 578 | 19% | 1.40 | 215 / 1155 |
| intestine | 10% | 26.23 | 98 / 966 | 6% | 0.39 | 34 / 527 |
| thymus | 0% | 0.36 | 1 / 653 | 11% | 0.92 | 65 / 605 |
| pancreas | 0% | 0 | 0 / 328 | 8% | 0.97 | 15 / 178 |
| breast | 0% | 0 | 0 / 459 | 8% | 0.71 | 94 / 1118 |
| stomach | 1% | 1.05 | 2 / 359 | 7% | 0.35 | 19 / 286 |
| kidney | 0% | 0 | 0 / 89 | 5% | 0.31 | 43 / 901 |
| liver | 1% | 3.52 | 3 / 226 | 2% | 0.12 | 9 / 406 |
| prostate | 3% | 6.07 | 7 / 245 | 0% | 0.01 | 1 / 502 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.15 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0060236 | Biological process | regulation of mitotic spindle organization |
| GO_0051301 | Biological process | cell division |
| GO_0031122 | Biological process | cytoplasmic microtubule organization |
| GO_0032465 | Biological process | regulation of cytokinesis |
| GO_0051302 | Biological process | regulation of cell division |
| GO_0005813 | Cellular component | centrosome |
| GO_0032154 | Cellular component | cleavage furrow |
| GO_0005874 | Cellular component | microtubule |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0008017 | Molecular function | microtubule binding |
| Gene name | FSD1 |
| Protein name | Fibronectin type III and SPRY domain-containing protein 1 (MID1-related protein 1) (Microtubule-associated protein GLFND) Fibronectin type III and SPRY domain containing 1 Fibronectin type III and SPRY domain-containing protein 1 |
| Synonyms | MIR1 VLP27 GLFND |
| Description | FUNCTION: May be involved in microtubule organization and stabilization. . FUNCTION: May be involved in microtubule organization and stabilization. . |
| Accessions | ENST00000597480.1 ENST00000597590.5 ENST00000594438.1 M0R2F6 ENST00000601006.1 M0R366 ENST00000221856.11 M0QY68 Q9BTV5 M0R1R0 |
